| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/13/2006 | US20060079442 Methods and uses of leptin in immune modulation and hepatocellular carcinoma |
| 04/13/2006 | US20060078950 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 04/13/2006 | US20060078943 Method for obtaining anti-idiotype antibodies |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078932 Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes |
| 04/13/2006 | US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 04/13/2006 | US20060078901 Listeria monocytogenes genome, polypeptides and uses |
| 04/13/2006 | US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 04/13/2006 | US20060078874 Use of nuclear hormone receptors |
| 04/13/2006 | US20060078572 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever |
| 04/13/2006 | US20060078571 Methods for treating inflammation pain |
| 04/13/2006 | US20060078567 Method of preventing acute pulmonary cell injury |
| 04/13/2006 | US20060078566 Antigen ORF Rv2430c and a method thereof |
| 04/13/2006 | US20060078565 Nucleic acids and proteins from Group B Streptococcus |
| 04/13/2006 | US20060078564 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 04/13/2006 | US20060078563 Using heat shock proteins to increase immune response |
| 04/13/2006 | US20060078562 RAGE fusion proteins and methods of use |
| 04/13/2006 | US20060078561 Polyclonal antibody libraries |
| 04/13/2006 | US20060078560 Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| 04/13/2006 | US20060078559 Detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity using a heme binding protein (HBP) polypeptide as a modulating agents of polypeptide activity;. antibodies against FPRL2; drug screening for treating diseases characterized by dysregulation of FPRL2 polypeptide signal transduction |
| 04/13/2006 | US20060078558 Diagnosis, prognosis and treatment of pulmonary diseases |
| 04/13/2006 | US20060078557 Methods and compositions for promoting immunopotentiation |
| 04/13/2006 | US20060078556 Antibodies and epitopes specific to tRNA synthetase fragments |
| 04/13/2006 | US20060078554 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 04/13/2006 | US20060078550 Porcine fgl2 |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078544 generating an enhanced immune response to a prostate tumor associated antigen by administering a composition comprising allogeneic cancer cells that have been rendered proliferation-incompetent and have been genetically engineered to express granulocyte-macrophage colony stimulating factor (GM-CSF) |
| 04/13/2006 | US20060078539 Remedies for tumor in hematopoietic organs |
| 04/13/2006 | US20060078535 Anticancer compounds and methods |
| 04/13/2006 | US20060078533 Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer |
| 04/13/2006 | US20060078532 Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease |
| 04/13/2006 | US20060078498 Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192 |
| 04/13/2006 | US20060078490 Synthesis of water soluble nanocrystalline quantum dots and uses thereof |
| 04/13/2006 | DE10021433B4 Verfahren zur Herstellung eines antiviralen Mittels Process for the preparation of an antiviral agent |
| 04/13/2006 | CA2615139A1 Piscirickettsia salmonis antigens and use thereof |
| 04/13/2006 | CA2589602A1 Adenoviral vectors able to transduce apcs, potential use in immune response generation |
| 04/13/2006 | CA2588274A1 Vlp-antigen conjugates and their uses as vaccines |
| 04/13/2006 | CA2583689A1 Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 04/13/2006 | CA2583431A1 Variant amyloid protein |
| 04/13/2006 | CA2583417A1 Antagonists and methods of use therefor |
| 04/13/2006 | CA2583221A1 Combination vaccine |
| 04/13/2006 | CA2583065A1 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 04/13/2006 | CA2583061A1 Antibody production method |
| 04/13/2006 | CA2582937A1 Formulation of multivalent antibody constructs and use of same for cancer therapy |
| 04/13/2006 | CA2582683A1 Novel antibodies directed to the mammalian eag1 ion channel protein |
| 04/13/2006 | CA2582471A1 Type i interferon blocking agents for prevention and treatment of psoriasis |
| 04/13/2006 | CA2582426A1 Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection |
| 04/13/2006 | CA2582016A1 Methods of treating cd30 positive lymphomas |
| 04/13/2006 | CA2581554A1 Hepatitis c virus replication system |
| 04/13/2006 | CA2580967A1 Irta-4 antibodies and their uses |
| 04/12/2006 | EP1645875A1 Diagnosis and therapy of cell proliferative disorders characterized by resistance to TRAIL induced apoptosis |
| 04/12/2006 | EP1645635A2 Replication defective recombinant retroviruses expressing a palliative |
| 04/12/2006 | EP1645634A2 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/12/2006 | EP1645631A2 Neisseria antigens and compositions |
| 04/12/2006 | EP1645567A1 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 04/12/2006 | EP1645292A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645291A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645290A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645289A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645285A2 Therapeutical use of anti-mag antibody for the treatment of ischemic stroke |
| 04/12/2006 | EP1645284A1 Use of ligands of the antigen CDw52 for the treatment of diseases that are related to degenerated macrophages |
| 04/12/2006 | EP1645283A1 Combination vaccine |
| 04/12/2006 | EP1644729A2 Anti-cd74 immunoconjugates and methods |
| 04/12/2006 | EP1644492A2 Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 04/12/2006 | EP1644489A2 Novel immune booster compound, compositions comprising the same and methods using said booster compound |
| 04/12/2006 | EP1644484A1 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations |
| 04/12/2006 | EP1644414A2 Binding molecules against sars-coronavirus and uses thereof |
| 04/12/2006 | EP1644408A1 Eimeria tenella antigen for immunotherapy of coccidiosis |
| 04/12/2006 | EP1644407A1 Uses of a novel eimeria gene and corresponding protein |
| 04/12/2006 | EP1644405A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 04/12/2006 | EP1644048A2 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
| 04/12/2006 | EP1644039A2 Compositions and methods for treating coagulation related disorders |
| 04/12/2006 | EP1644038A2 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 04/12/2006 | EP1644037A2 Functional influenza virus-like particles (vlps) |
| 04/12/2006 | EP1644036A2 Immunization method against neisseria meningitidis serogroups a and c |
| 04/12/2006 | EP1644035A1 Ultrafiltration for preparing outer membrane vesicles |
| 04/12/2006 | EP1644034A1 Packaged virus-like particles |
| 04/12/2006 | EP1644020A2 Lyase treatment for p. carinii |
| 04/12/2006 | EP1643979A1 Pharmaceutical aerosol composition |
| 04/12/2006 | EP1334174B1 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1299130B1 A method of treating and preventing infectious diseases |
| 04/12/2006 | EP1263448B1 Maca and antler for augmenting testosterone levels |
| 04/12/2006 | EP1192247B1 Sphingosine kinase enzyme |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0861319B1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 04/12/2006 | EP0491824B2 Human parvovirus b19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| 04/12/2006 | CN1759123A Uses of IL-23 agonists and antagonists; related reagents |
| 04/12/2006 | CN1759121A Purification process for bacterial cytolysin |
| 04/12/2006 | CN1758923A Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
| 04/12/2006 | CN1758922A Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 04/12/2006 | CN1758900A Pharmaceutical composition |
| 04/12/2006 | CN1758899A Dosage form having a saccharide matrix |
| 04/12/2006 | CN1757725A siRNA capable of inhibiting foot and mouth disease virus replication and infection and its preparation method |
| 04/12/2006 | CN1757413A Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 04/12/2006 | CN1757398A Method for preparing inorganic salt nanometer particles containing and packing traditional Chinese medicine and its application |
| 04/12/2006 | CN1250737C PCR process for preparing CpG DNA containing livestock and bird vaccine adjuvant |
| 04/12/2006 | CN1250731C Packaging of positive-strand RNA virus replicon particles |
| 04/12/2006 | CN1250725C Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |